Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?
Cancer Biomarkers · 2025
DOI: 10.3233/cbm-230360 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Biomarkers, 2025. Verfasst von Roger Y Kim. Beteiligte Einrichtung: Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA,…. Hauptthemen laut MEDLINE: Artificial Intelligence, Multiple Pulmonary Nodules, Lung Neoplasms, Solitary Pulmonary Nodule. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Pulmonary nodules are ubiquitously found on computed tomography (CT) imaging either incidentally or via lung cancer screening and require careful diagnostic evaluation and management to both diagnose malignancy when present and avoid unnecessary biopsy of benign lesions. To engage in this complex decision-making, clinicians must first risk stratify pulmonary nodules to determine what the best course of action should be. Recent developments in imaging technology, computer processing power, and artificial intelligence algorithms have yielded radiomics-based computer-aided diagnosis tools that use CT imaging data including features invisible to the naked human eye to predict pulmonary nodule malignancy risk and are designed to be used as a supplement to routine clinical risk assessment. These tools vary widely in their algorithm construction, internal and external validation populations, intended-use populations, and commercial availability. While several clinical validation studies have been published, robust clinical utility and clinical effectiveness data are not yet currently available. However, there is reason for optimism as ongoing and future studies aim to target this knowledge gap, in the hopes of improving the diagnostic process for patients with pulmonary nodules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Kim, R. Y. (2025). Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?. Cancer Biomarkers. https://doi.org/10.3233/cbm-230360
Vancouver
Kim RY. Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?. Cancer Biomarkers. 2025. doi:10.3233/cbm-230360
BibTeX
@article{Kim2025,
author = {Kim, Roger Y},
title = {Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?},
journal = {Cancer Biomarkers},
year = {2025},
doi = {10.3233/cbm-230360}
}
EUVIMED